ArticleOxford medical case reports2026
An unusually small pituitary microadenoma causing severe Cushing disease in a male patient: lessons from early Radiosurgical management.
Article in Oxford medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cushing disease is a rare endocrine disorder caused by an ACTH-secreting pituitary adenoma. We report a 27-year-old male with severe hypercortisolism due to a 1.2-mm pituitary microadenoma. He presented with facial plethora, centripetal obesity, violaceous striae, hypertension, diabetes, dyslipidemia, and fatigue. Biochemical testing confirmed ACTH-dependent hypercortisolism, and 3 T MRI identified the lesion. Owing to its minute size and the anticipated difficulty of surgical localization, transsphenoidal surgery was deferred and Gamma Knife radiosurgery (GKRS) was performed as first-line therapy. After 5 months, biochemical hypercortisolism persisted, with elevated cortisol and ACTH levels. Ketoconazole 200 mg daily was subsequently initiated, resulting in normalization of serum cortisol within four weeks, ACTH levels remained elevated. Mild transient ALT elevation was observed during treatment. This case highlights that very small adenomas can cause severe disease and underscores the delayed response to GKRS, necessitating early adjunctive medical therapy to control hypercortisolism and reduce morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.